Impact of lifestyle modification on glycemic control and cognitive function among Type II diabetes mellitus patients

• Published in: Future science OA Vol. 9; no. 1; p. FSO835
• Main Authors: Salama, Iman I, Sami, Samia M, Salama, Somaia I, Abdel-Latif, Ghada A, Aboulghate, Ahmed, Raslan, Hala M, Mohsen, Amira, Rasmy, Hanaa, Ibrahim, Mona Hamed, Ganem, Mona Mf, Abdelmohsen, Aida M, El-Etreby, Lobna A, Ibrahim, Nihad A, Fouad, Walaa A, El-Deeb, Sherif E
• Format: Journal Article
• Language: English
• Published: England Future Science Ltd 01.01.2023
• Subjects: cognitive function; glycemic control; lifestyle modification; T2DM; cognitive function; T2DM; glycemic control; lifestyle modification
• ISSN: 2056-5623; 2056-5623
• DOI: 10.2144/fsoa-2022-0060

Assessing impact of lifestyle modification on Type 2 diabetes mellitus (T2DM) glycemic control and cognitive function. Prospective study was conducted on T2DM patients (92 patients as interventional group and 92 patients conventional therapy). After 6 months, significant improvements of HbA1c, oxidant and antioxidant, lipid profile, and cognitive function among only the interventional group (p < 0.05). Using logistic analysis, conventional therapy, DM duration >10 years, lower education, HbA1c baseline >7 were significant predictive risks for uncontrolled DM (AOR 4.2, 2.9, 2.7 and 2.2, respectively). While, conventional therapy, baseline mild cognitive impairment (MCI) and females were significant risks for MCI (AOR 11.5, 10.8 and 4.8, respectively). Lifestyle modification is a very important for glycemic control and cognitive function. : ( ) The study aimed at assessing the effect of lifestyle modification program on Type 2 diabetes mellitus (T2DM) patients. The program contents include maintaining healthy diet depending on glycemic index and CHO counting, adjusting cholesterol level, regular physical activity for at least 30 minutes; 3–5 days per week, weight loss and maintaining an appropriate weight, controlling the blood pressure, smoking cessation and practicing mental activity. After 6 months, there was a significant improvement in glycemic control, cognitive function, oxidant and antioxidant and lipid profile levels among patients participating in the program but not among those remained on the conventional therapy.